[The efficacy of Capoten in different clinical courses of acute myocardial infarct].
Mikashinovich
Z I
ZI
Terent'ev
V P
VP
Shlyk
S V
SV
Suroedova
R A
RA
Shepelev
A A
AA
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000097:blood / Q000503:physiopathology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001692:Biological Transport / Q000187:drug effects; D002216:Captopril / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000097:blood / Q000209:etiology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D010100:Oxygen / Q000097:blood; D005082:Physical Exertion; D013997:Time Factors; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril; D010100:Oxygen